Titus B. Ball - 19 Mar 2024 Form 3 Insider Report for BeiGene, Ltd. (ONC)

Role
Principal Accounting Officer
Signature
/s/ Qing Nian, as Attorney-in-Fact
Issuer symbol
ONC
Transactions as of
19 Mar 2024
Net transactions value
$0
Form type
3
Filing time
26 Mar 2024, 17:26:42 UTC
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BGNE Ordinary Shares 23,478 19 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BGNE Share Option (Right to Buy) 19 Mar 2024 Ordinary Shares 14,677 $15.97 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying unvested restricted share units.
F2 These securities vest over a four-year period as follows: 25% on August 31, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney